Amarin Corp Plc (AMRN)

[rafunrafun]

Scripts for week ending May 20, 2022

Drug Industry TRx: -1.1% w/w; +7.8% y/y

Vascepa
TRx 65,736; -0.9% (-574) w/w; -20.1% y/y
NRx 30,290; -2.0% (-622) w/w; -16.9% y/y
Ref 35,446; +0.1% (+49) w/w; -22.6% y/y

Lovaza (Generic & Brand)
TRx 61,961; -2.2% (-1,398) w/w; -1.1% y/y
NRx 31,301; -1.8% (-561) w/w; +2.9% y/y
Ref 30,660; -2.7% (-838) w/w; -4.9% y/y

Generic Vascepa
TRx 36,953; -2.1% (-791) w/w; As % of total V: 36.0%
NRx 20,592; -2.5% (-521) w/w; As % of total V: 40.5%
Ref 16,360; -1.6% (-269) w/w; As % of total V: 31.6%

Generic Vascepa by Manufacturer
Hikma - TRx 9,722; (-170) w/w; Generic share 26.3%; Total V share 9.5%
Reddy - TRx 18,579; (-57) w/w; Generic share 50.3%; Total V share 18.1%
Apotex - TRx 8,652; (-562) w/w; Generic share 23.4%; Total V share 8.4%

Vascepa + Generic Vascepa
TRx 102,688; -1.3% (-1,364) w/w; +8.6% y/y
NRx 50,882; -2.2% (-1,143) w/w; +17.7% y/y
Ref 51,806; -0.4% (-221) w/w; +0.9% y/y